Browse result page of B3Pdb

The total number entries retrieved from this search are 507, scroll left/right for detailed information.
B3pdbIDPEPTIDE NAMEPEPTIDE SEQUENCE (1-letter)PEPTIDE SEQUENCE (3-letter)N-TERMINAL MODIFICATIONC-TERMINAL MODIFICATION CHEMICAL MODIFICATIONPEPTIDE LENGTHPEPTIDE CONFORMATIONPEPTIDE NATURESOURCE/ORIGIN OF PEPTIDESMILESCELL LINEIn vitro CONCENTRATIONIn vitro METHODIn vitro RESULTANIMAL MODELIn vivo CONCENTRATIONIn vivo MODE OF DELIVERYIn vivo METHODIn vivo RESULTACTIONTRANSPORT TYPESUBCELLULAR LOCALISATIONCOMBINATIONPHYSICAL CONDITIONRESPONSERESULTLABELPMID
b3pdb_0911Angiopep-7TFFYGGSRGRRNNFRTEEYThr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Arg-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-TyrNANANA19LinearNAChemically synthesizedNANANACapillary deplition in situ b pNANANANANANA NA NA NA NA NA CD(capillary/perfusate) 0.0183 ml/g Direct iodination 18156463
b3pdb_0912Angiopep-7TFFYGGSRGRRNNFRTEEYThr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Arg-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-TyrNANANA19LinearNAChemically synthesizedNANANACapillary deplition in situ b pNANANANANANA NA NA NA NA NA CD(brain/perfusate) 0.061 ml/g Direct iodination 18156463
b3pdb_0913Angiopep-7TFFYGGSRGRRNNFRTEEYThr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Arg-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-TyrNANANA19LinearNAChemically synthesizedNANANACapillary deplition in situ b pNANANANANANA NA NA NA NA NA CD(brain/perfusate) 0.054 ml/g Direct iodination 19818094
b3pdb_0914Angiopep-7TFFYGGSRGRRNNFRTEEYThr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Arg-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-TyrNANANA19LinearNAChemically synthesizedNANANACapillary deplition in situ b pNANANANANANA NA NA NA NA NA CD(capillary/perfusate) 0.024 ml/g Direct iodination 19818094
b3pdb_0915Angiopep-7TFFYGGSRGRRNNFRTEEYThr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Arg-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-TyrNANANA19LinearNAChemically synthesizedNANANACapillary deplition in situ b pNANANANANANA NA NA NA NA NA CD(parenchyma/perfusate) 0.03 ml/g Direct iodination 18489712
b3pdb_0916Angiopep-7TFFYGGSRGRRNNFRTEEYThr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Arg-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-TyrNA19LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA NA NA NA NA % injected dose 0.032 %/g Direct iodination 29090274
b3pdb_0917Exendin-4-NH2HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2NANANA19LinearNAChemically synthesizedCCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O) NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC (CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(= O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C) C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C (CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C (CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC (=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CN=CN9)NNANACapillary depletionNANANANANANA NA NA NA NA NA % capillary 20.22% Direct iodination 18489712
b3pdb_0918Exendin-4-NH2HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2NANANA19LinearNAChemically synthesizedCCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O) NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC (CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(= O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C) C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C (CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C (CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC (=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CN=CN9)NNANACapillary depletionNANANANANANA NA NA NA NA NA % parenchyma 79.78% Direct iodination 18489712
b3pdb_0919Exendin-4-NH2HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2NANANA19LinearNAChemically synthesizedCCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O) NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC (CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(= O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C) C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C (CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C (CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC (=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CN=CN9)NNANACapillary deplition in situ b pNANANANANANA NA NA NA NA NA CD(brain/perfusate) 0.0183 ml/g Direct iodination 18489712
b3pdb_0920Exendin-4-NH2HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2NANANA19LinearNAChemically synthesizedCCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O) NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC (CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(= O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C) C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C (CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C (CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC (=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CN=CN9)NNANACapillary deplition in situ b pNANANANANANA NA NA NA NA NA CD(parenchyma/perfusate) 0.0146 ml/g Direct iodination 18489712
b3pdb_0921Exendin-4-NH2HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2NANANA19LinearNAChemically synthesizedCCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O) NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC (CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(= O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C) C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C (CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C (CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC (=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CN=CN9)NNANACapillary deplition in situ b pNANANANANANA NA NA NA NA NA CD(capillary/perfusate) 0.0037 ml/g Direct iodination 18489712
b3pdb_0922OncocinVDKPPYLPRPRPPRRIYNR-NH2Val-Asp-Lys-Pro-Pro-Tyr-Leu-Pro-Arg-Pro-Arg-Pro-Pro-Arg-Arg-Ile-Tyr-Asn-Arg-NH2NANANA19LinearNAChemically synthesizedNANANAEfflux study ICUNANANANANANA NA Permeability NA NA NA Brain elemination rate constant 0.002 min-1 Direct iodination 24164260
b3pdb_0923OncocinVDKPPYLPRPRPPRRIYNR-NH2Val-Asp-Lys-Pro-Pro-Tyr-Leu-Pro-Arg-Pro-Arg-Pro-Pro-Arg-Arg-Ile-Tyr-Asn-Arg-NH2NANANA19LinearNAChemically synthesizedNANANACapillary depletionNANANANANANA NA NA NA NA NA % capillary 82% Direct iodination 24164260
b3pdb_0924OncocinVDKPPYLPRPRPPRRIYNR-NH2Val-Asp-Lys-Pro-Pro-Tyr-Leu-Pro-Arg-Pro-Arg-Pro-Pro-Arg-Arg-Ile-Tyr-Asn-Arg-NH2NANANA19LinearNAChemically synthesizedNANANACapillary depletionNANANANANANA NA NA NA NA NA % parenchyma 18% Direct iodination 24164260
b3pdb_0925OncocinVDKPPYLPRPRPPRRIYNR-NH2Val-Asp-Lys-Pro-Pro-Tyr-Leu-Pro-Arg-Pro-Arg-Pro-Pro-Arg-Arg-Ile-Tyr-Asn-Arg-NH2NANANA19LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Unidirectional influx rate constant 0.00044 mL/(g x min) Direct iodination 24164260
b3pdb_0926OncocinVDKPPYLPRPRPPRRIYNR-NH2Val-Asp-Lys-Pro-Pro-Tyr-Leu-Pro-Arg-Pro-Arg-Pro-Pro-Arg-Arg-Ile-Tyr-Asn-Arg-NH2NANANA19LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Initial disrobution volume 0.02584 ml/g Direct iodination 24164260
b3pdb_0947CycSY-cyclo(aGF-(Nω-methylguanidino)A-)-NH2Tyr-cyclo((D)Ala-Gly-Phe-Nω-methylguanidinoAla-)-NH2NANANA5LinearNAChemically synthesizedNANANAEfflux study ICUNANANANANANA NA Permeability NA NA NA Brain elemination rate constant -0.1 min-1 Direct iodination 25451468
b3pdb_0948CycSY-cyclo(aGF-(Nω-methylguanidino)A-)-NH2Tyr-cyclo((D)Ala-Gly-Phe-Nω-methylguanidinoAla-)-NH2NANANA5LinearNAChemically synthesizedNANANACapillary depletionNANANANANANA NA NA NA NA NA % capillary 21.44% Direct iodination 25451468
b3pdb_0949CycSY-cyclo(aGF-(Nω-methylguanidino)A-)-NH2Tyr-cyclo((D)Ala-Gly-Phe-Nω-methylguanidinoAla-)-NH2NANANA5LinearNAChemically synthesizedNANANACapillary depletionNANANANANANA NA NA NA NA NA % parenchyma 78.56% Direct iodination 25451468
b3pdb_0950CycSY-cyclo(aGF-(Nω-methylguanidino)A-)-NH2Tyr-cyclo((D)Ala-Gly-Phe-Nω-methylguanidinoAla-)-NH2NANANA5LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Unidirectional influx rate constant 0.00011 mL/(g x min) Direct iodination 25451468
b3pdb_0951CycSY-cyclo(aGF-(Nω-methylguanidino)A-)-NH2Tyr-cyclo((D)Ala-Gly-Phe-Nω-methylguanidinoAla-)-NH2NANANA5LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Initial disrobution volume 0.02336 ml/g Direct iodination 25451468
b3pdb_0952CycNMeY-cyclo(aGF-(Nω-methylguanidino)A-)-NH2Tyr-cyclo((D)Ala-Gly-Phe-Nω-methylguanidinoAla-)-NH2NANANA5LinearNAChemically synthesizedNANANAEfflux study ICUNANANANANANA NA Permeability NA NA NA Brain elemination rate constant -0.06 min-1 Direct iodination 25451468
b3pdb_0953CycNMeY-cyclo(aGF-(Nω-methylguanidino)A-)-NH2Tyr-cyclo((D)Ala-Gly-Phe-Nω-methylguanidinoAla-)-NH2NANANA5LinearNAChemically synthesizedNANANACapillary depletionNANANANANANA NA NA NA NA NA % capillary 28.74% Direct iodination 25451468
b3pdb_0954CycNMeY-cyclo(aGF-(Nω-methylguanidino)A-)-NH2Tyr-cyclo((D)Ala-Gly-Phe-Nω-methylguanidinoAla-)-NH2NANANA5LinearNAChemically synthesizedNANANACapillary depletionNANANANANANA NA NA NA NA NA % parenchyma 71.26% Direct iodination 25451468
b3pdb_0955CycNMeY-cyclo(aGF-(Nω-methylguanidino)A-)-NH2Tyr-cyclo((D)Ala-Gly-Phe-Nω-methylguanidinoAla-)-NH2NANANA5LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Unidirectional influx rate constant 0.00031 mL/(g x min) Direct iodination 25451468
b3pdb_0956CycNMeY-cyclo(aGF-(Nω-methylguanidino)A-)-NH2Tyr-cyclo((D)Ala-Gly-Phe-Nω-methylguanidinoAla-)-NH2NANANA5LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Initial disrobution volume 0.01812 ml/g Direct iodination 25451468
b3pdb_0957mouse GhrelinGSS(octanoyl)FLSPEHQKAQQRKESKKPPAKLQPRGly-Ser-Ser(Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-ArgNANANA28LinearNAChemically synthesizedNANANAEfflux study ICUNANANANANANA NA saturable NA NA NA half life, brain 16.4 min Direct iodination 12130749
b3pdb_0958mouse GhrelinGSS(octanoyl)FLSPEHQKAQQRKESKKPPAKLQPRGly-Ser-Ser(Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-ArgNANANA28LinearNAChemically synthesizedNANANAEfflux study ICUNANANANANANA NA saturable NA NA NA Brain elemination rate constant 0.042 min-1 Direct iodination 12130749
b3pdb_0959mouse GhrelinGSS(octanoyl)FLSPEHQKAQQRKESKKPPAKLQPRGly-Ser-Ser(Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-ArgNANANA28LinearNAChemically synthesizedNANANAHPLCNANANANANANA NA NA NA NA NA % injected dose 0.01 %/g Direct iodination 12130749
b3pdb_0960mouse GhrelinGSS(octanoyl)FLSPEHQKAQQRKESKKPPAKLQPRGly-Ser-Ser(Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-ArgNANANA28LinearNAChemically synthesizedNANANAHPLCNANANANANANA NA NA NA NA NA % injected dose 0.005 %/g Direct iodination 12130749
b3pdb_0961mouse GhrelinGSS(octanoyl)FLSPEHQKAQQRKESKKPPAKLQPRGly-Ser-Ser(Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-ArgNANANA28LinearNAChemically synthesizedNANANAShake FlaskNANANANANANA NA NA NA NA NA Log P -1.24 Direct iodination 12130749
b3pdb_0962mouse GhrelinGSS(octanoyl)FLSPEHQKAQQRKESKKPPAKLQPRGly-Ser-Ser(Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-ArgNA28LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Unidirectional influx rate constant 0.0001852 mL/(g x min) Direct iodination 30293893
b3pdb_0963mouse GhrelinGSS(octanoyl)FLSPEHQKAQQRKESKKPPAKLQPRGly-Ser-Ser(Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-ArgNA28LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Initial disrobution volume 0.002847 ml/g Direct iodination 30293893
b3pdb_0964ANG1005(2'-N-succinimide-paclitaxel)TFFYGGSRG-(2'-N-succinimide-paclitaxel)KRNNF(2'-N-succinimide-paclitaxel)KTEEY(2'-N-succinimide-paclitaxel)Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-(2'-N-succinimide-paclitaxel)Lys-Arg-Asn-Asn-Phe-(2'-N-succinimide-paclitaxel)Lys-Thr-Glu-Glu-TyrNANANA19LinearNAChemically synthesizedNANANACapillary deplition in situ b pNANANANANANA NA NA NA NA NA CD(brain/perfusate) 0.9333 ml/g H3/C14 18574456
b3pdb_0965ANG1005(2'-N-succinimide-paclitaxel)TFFYGGSRG-(2'-N-succinimide-paclitaxel)KRNNF(2'-N-succinimide-paclitaxel)KTEEY(2'-N-succinimide-paclitaxel)Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-(2'-N-succinimide-paclitaxel)Lys-Arg-Asn-Asn-Phe-(2'-N-succinimide-paclitaxel)Lys-Thr-Glu-Glu-TyrNANANA19LinearNAChemically synthesizedNANANACapillary deplition in situ b pNANANANANANA NA NA NA NA NA CD(capillary/perfusate) 0.3111 ml/g H3/C14 18574456
b3pdb_0966ANG1005(2'-N-succinimide-paclitaxel)TFFYGGSRG-(2'-N-succinimide-paclitaxel)KRNNF(2'-N-succinimide-paclitaxel)KTEEY(2'-N-succinimide-paclitaxel)Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-(2'-N-succinimide-paclitaxel)Lys-Arg-Asn-Asn-Phe-(2'-N-succinimide-paclitaxel)Lys-Thr-Glu-Glu-TyrNANANA19LinearNAChemically synthesizedNANANACapillary deplition in situ b pNANANANANANA NA NA NA NA NA CD(parenchyma/perfusate) 0.5037 ml/g H3/C14 18574456
b3pdb_0969Doxorubicin-SynB1Doxorubicin-linker-RGGRLSYSRRRFSTSTGRDoxorubicin-linker-Arg-Gly-Gly-Arg-Leu-Ser-Tyr-Ser-Arg-Arg-Arg-Phe-Ser-Thr-Ser-Thr-Gly-ArgNANANA18LinearNAChemically synthesizedNANANANANANANAIn situ perfusion (single time)NANA NA Permeability NA NA NA Unidirectonal influx rate constant 0.0684 mL/(g x min) H3/C14 12164379
b3pdb_0970Doxorubicin-(D)-PeneDoxorubicin-linker-rqikiwfqnrrmkwkkDoxorubicin-linker-(D)Arg-(D)Gln-(D)Ile-(D)Lys-(D)Ile-(D)Trp-(D)Phe-(D)Gln-(D)Asn-(D)Arg-(D)Arg-(D)Met-(D)Lys-(D)Trp-(D)Lys-(D)LysNA16LinearNAChemically synthesizedNANANANANANANAin situ brain perfusionNANA NA Permeability NA NA NA Volume of donor compartment 0.77764 ml/g H3/C14 11123372
b3pdb_0971Doxorubicin-(D)-PeneDoxorubicin-linker-rqikiwfqnrrmkwkkDoxorubicin-linker-(D)Arg-(D)Gln-(D)Ile-(D)Lys-(D)Ile-(D)Trp-(D)Phe-(D)Gln-(D)Asn-(D)Arg-(D)Arg-(D)Met-(D)Lys-(D)Trp-(D)Lys-(D)LysNANANA16LinearNAChemically synthesizedNANANANANANANAIn situ perfusion (single time)NANA NA Permeability NA NA NA Unidirectonal influx rate constant 0.072 mL/(g x min) H3/C14 10727512
b3pdb_0973Doxorubicin-(D)-SynBDoxorubicin-linker-rrlsysrrrfDoxorubicin-linker-(D)Arg-(D)Arg-(D)Leu-(D)Ser-(D)Tyr-(D)Ser-(D)Arg-(D)Arg-(D)Arg-(D)PheNA10LinearNAChemically synthesizedNANANANANANANAin situ brain perfusionNANA NA Permeability NA NA NA Volume of donor compartment 0.9618 ml/g H3/C14 11123372
b3pdb_0974SynB3RRLSYSRRRF-NH2Arg-Arg-Leu-Ser-Tyr-Ser-Arg-Arg-Arg-Phe-NH2NA10LinearNAChemically synthesizedNANANANANANANAin situ brain perfusionNANA NA Permeability NA NA NA Volume of donor compartment 0.7884 ml/g H3/C14 11123372
b3pdb_0975Tat 47-57YGRKKRRQRRR-NH2Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-NH2NANANA11LinearNAChemically synthesizedNANANAEfflux study ICUNANANANANANA NA Permeability NA NA NA Brain elemination rate constant 0.05 min-1 Direct iodination 26465925
b3pdb_0976Tat 47-57YGRKKRRQRRR-NH2Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-NH2NANANA11LinearNAChemically synthesizedNANANAShake FlaskNANANANANANA NA NA NA NA NA % capillary 23.05% Direct iodination 26465925
b3pdb_0977Tat 47-57YGRKKRRQRRR-NH2Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-NH2NANANA11LinearNAChemically synthesizedNANANAShake FlaskNANANANANANA NA NA NA NA NA % parenchyma 76.95% Direct iodination 26465925
b3pdb_0978Tat 47-57YGRKKRRQRRR-NH2Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-NH2NANANA11LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Unidirectional influx rate constant 0.00563 mL/(g x min) Direct iodination 26465925
b3pdb_0979Tat 47-57YGRKKRRQRRR-NH2Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-NH2NANANA11LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Initial disrobution volume 0.02762 ml/g Direct iodination 26465925
b3pdb_0980pVECLLIILRRRIRKQAHAHSK-NH2Leu-Leu-Ile-Ile-Leu-Arg-Arg-Arg-Ile-Arg-Lys-Gln-Ala-His-Ala-His-Ser-Lys-NH2NANANA18LinearNAChemically synthesizedNANANAEfflux study ICUNANANANANANA NA Permeability NA NA NA Brain elemination rate constant 0.1019 min-1 Direct iodination 26465925
b3pdb_0981pVECLLIILRRRIRKQAHAHSK-NH2Leu-Leu-Ile-Ile-Leu-Arg-Arg-Arg-Ile-Arg-Lys-Gln-Ala-His-Ala-His-Ser-Lys-NH2NANANA18LinearNAChemically synthesizedNANANACapillary depletionNANANANANANA NA NA NA NA NA % capillary 19.53% Direct iodination 26465925
b3pdb_0982pVECLLIILRRRIRKQAHAHSK-NH2Leu-Leu-Ile-Ile-Leu-Arg-Arg-Arg-Ile-Arg-Lys-Gln-Ala-His-Ala-His-Ser-Lys-NH2NANANA18LinearNAChemically synthesizedNANANACapillary depletionNANANANANANA NA NA NA NA NA % parenchyma 80.47% Direct iodination 26465925
b3pdb_0983pVECLLIILRRRIRKQAHAHSK-NH2Leu-Leu-Ile-Ile-Leu-Arg-Arg-Arg-Ile-Arg-Lys-Gln-Ala-His-Ala-His-Ser-Lys-NH2NANANA18LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Unidirectional influx rate constant 0.00602 mL/(g x min) Direct iodination 26465925